Global Immunoprecipitation Industry

Summary

Abstract:

What’s New for 2022?

Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year

Global Immunoprecipitation Market to Reach $826.1 Million by 2027

In the changed post COVID-19 business landscape, the global market for Immunoprecipitation estimated at US$556.3 Million in the year 2020, is projected to reach a revised size of US$826.1 Million by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Reagents, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$375.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Kits segment is readjusted to a revised 6.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $151.5 Million, While China is Forecast to Grow at 9.2% CAGR

The Immunoprecipitation market in the U.S. is estimated at US$151.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$173.6 Million by the year 2027 trailing a CAGR of 9.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 4.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$111.3 Million by the year 2027.



Accessories Segment to Record 4.9% CAGR

In the global Accessories segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$104.7 Million in the year 2020 will reach a projected size of US$143.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 5.3% CAGR through the analysis period.

Select Competitors (Total 42 Featured) -
Abbkine Scientific Co. Ltd.
Abcam PLC
BioLegend
Bio-Rad Laboratories
Cell Signaling Technology Inc.
Geno Technology Inc.
GenScript Biotech Corporation
Merck KGaA
Rockland Immunochemicals Inc.
Takara Bio Inc.
Thermo Fisher Scientific

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.

Related Topics